BIOMAT Database Logo BIOMAT Database Logo

Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment. 1998

C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013967 Thyroiditis, Autoimmune Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis. Autoimmune Thyroiditis,Thyroiditis, Lymphocytic,Thyroiditis, Lymphomatous,Autoimmune Thyroiditides,Lymphocytic Thyroiditides,Lymphocytic Thyroiditis,Lymphomatous Thyroiditides,Lymphomatous Thyroiditis,Thyroiditides, Autoimmune,Thyroiditides, Lymphocytic,Thyroiditides, Lymphomatous
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Autoimmune thyroiditis and myelosuppression following treatment with interferon-alpha for hepatitis C.
April 1999, International journal of clinical pharmacology and therapeutics,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Delirium with autoimmune thyroiditis induced by interferon alpha.
October 2000, The American journal of psychiatry,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Anti-interferon alpha treatment in SLE.
September 2013, Clinical immunology (Orlando, Fla.),
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Multiple autoimmune syndrome: Hashimoto's thyroiditis, coeliac disease and systemic lupus erythematosus (SLE).
October 2010, JPMA. The Journal of the Pakistan Medical Association,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy.
April 2012, Journal of infection in developing countries,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse.
January 2003, Clinical & developmental immunology,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha.
June 2011, The American journal of the medical sciences,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Inhibition of murine autoimmune thyroiditis by interferon.
January 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Cases of interferon-alpha and interferon-beta-induced thyroiditis.
January 2010, Folia medica,
C García-Porrúa, and M A González-Gay, and F Fernández-Lamelo, and J M Paz-Carreira, and E Lavilla, and M A González-López
Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
July 1990, British journal of cancer,
Copied contents to your clipboard!